Reported studies have shown increased expression of XPO1 in various types of cancer, including pancreatic, ovarian, glioma, lung, gastric, prostate, liver, cervical, multiple myeloid, leukemia, and colorectal cancers. Here, XPO1 is linked to central nervous system cancer.